Thomas Charles Merigan M.D.

Publication Details

• Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection.

  Campbell TB, Shulman NS, Johnson SC, Zolopa AR, Young RK, Bushman L, Fletcher CV, Lanier ER, Merigan TC, Kuritzkes DR. Clin Infect Dis. 2005; 41 (2): 236-42

  Maximum suppression of virus replication is often not achievable for persons infected with multidrug-resistant human immunodeficiency virus type 1 (HIV-1). Available data suggest that lamivudine contributes to partial viral suppression, despite the presence of M184V mutations and high-level phenotypic lamivudine resistance.

  PubMedID: 15983922